Fibromatosis Overview

Save information for later
Sign Up

Learn About Fibromatosis

What is the definition of Fibromatosis?
Fibromatosis refers to a group of conditions characterized by overgrowths of skin and connective tissue called fibromas. These fibromas are usually benign (non-cancerous). Fibromatosis can be classified by a person's age or by the location of the fibromas. The cause of Fibromatosis is often unknown.
What are the alternative names for Fibromatosis?
  • Fibromatosis
Who are the top Fibromatosis Local Doctors?
Francois Bertucci
Elite in Fibromatosis
Francois Bertucci
Elite in Fibromatosis
Francois Bertucci
Marseille, FR 

Francois Bertucci practices in Marseille, France. Mr. Bertucci is rated as an Elite expert by MediFind in the treatment of Fibromatosis. His top areas of expertise are Inflammatory Breast Cancer, Adult Soft Tissue Sarcoma, Breast Cancer, Hysterectomy, and Oophorectomy.

Elite in Fibromatosis
Bernd S. Kasper
Elite in Fibromatosis
Bernd S. Kasper
Mannheim, BW, DE 

Bernd Kasper practices in Mannheim, Germany. Mr. Kasper is rated as an Elite expert by MediFind in the treatment of Fibromatosis. His top areas of expertise are Desmoid Tumor, Fibromatosis, Adult Soft Tissue Sarcoma, and Liposarcoma.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Fibromatosis
Nicolas P. Penel
Elite in Fibromatosis
Nicolas P. Penel
Lille, FR 

Nicolas Penel practices in Lille, France. Mr. Penel is rated as an Elite expert by MediFind in the treatment of Fibromatosis. His top areas of expertise are Adult Soft Tissue Sarcoma, Fibromatosis, Desmoid Tumor, Hysterectomy, and Orchiectomy.

View All Doctors
What are the latest Fibromatosis Clinical Trials?
A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors
A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

Summary: The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring
Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring
Enrollment Status: Recruiting
Publish Date: September 26, 2025
Intervention Type: Other
Study Phase: Phase 2

Summary: This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a train...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center